Coatue Management Has Lifted Nvidia (NVDA) Stake By $244.49 Million; Puma Biotechnology (PBYI) Has 1.21 Sentiment

August 29, 2017 - By Stephen Andrade

Coatue Management Llc increased Nvidia Corp (NVDA) stake by 115.47% reported in 2016Q4 SEC filing. Coatue Management Llc acquired 2.31M shares as Nvidia Corp (NVDA)’s stock rose 26.83%. The Coatue Management Llc holds 4.30 million shares with $459.41M value, up from 2.00 million last quarter. Nvidia Corp now has $98.89B valuation. The stock declined 0.10% or $0.16 reaching $164.81 on the news. About 3.99M shares traded. NVIDIA Corporation (NASDAQ:NVDA) has risen 212.28% since August 29, 2016 and is uptrending. It has outperformed by 195.58% the S&P500.

Puma Biotechnology, Inc. is a biopharmaceutical firm that focuses on the development and commercialization of products for the treatment of cancer. The company has market cap of $3.46 billion. The Firm focuses on in-licensing the development and commercialization rights to over three drug candidates, including PB272 ), PB272 (neratinib (intravenous)) and PB357. It currently has negative earnings. Neratinib is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4.

Ratings analysis reveals 100% of Puma Biotech.’s analysts are positive. Out of 2 Wall Street analysts rating Puma Biotech., 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $88.0 while the high is $111.0. The stock’s average target of $99.50 is 6.93% above today’s ($93.05) share price. PBYI was included in 2 notes of analysts from September 21, 2016. The rating was upgraded by Stifel Nicolaus to “Buy” on Wednesday, September 21. As per Thursday, September 22, the company rating was maintained by Credit Suisse.

Redmile Group Llc holds 3.41% of its portfolio in Puma Biotechnology Inc for 1.29 million shares. Partner Fund Management L.P. owns 1.14 million shares or 0.99% of their US portfolio. Moreover, Weatherbie Capital Llc has 0.98% invested in the company for 253,802 shares. The New York-based Orbimed Advisors Llc has invested 0.89% in the stock. Partner Investment Management L.P., a California-based fund reported 18,293 shares.

About 630,559 shares traded. Puma Biotechnology Inc (PBYI) has risen 23.65% since August 29, 2016 and is uptrending. It has outperformed by 6.95% the S&P500.

Since January 1, 0001, it had 0 buys, and 3 sales for $157.55 million activity.

Investors sentiment increased to 1.21 in 2016 Q4. Its up 0.21, from 1 in 2016Q3. It is positive, as 69 investors sold NVDA shares while 306 reduced holdings. 121 funds opened positions while 183 raised stakes. 423.47 million shares or 3.26% less from 437.73 million shares in 2016Q3 were reported. Ballentine Partners Lc accumulated 3,527 shares or 0.03% of the stock. Polar Capital Llp holds 0.32% or 185,216 shares in its portfolio. American Bancorp holds 27 shares or 0% of its portfolio. Nikko Asset Americas holds 4,400 shares. Stonebridge Cap Mgmt Incorporated invested 0.1% of its portfolio in NVIDIA Corporation (NASDAQ:NVDA). Utah Retirement Systems owns 93,105 shares. Mason Street Ltd Liability Corp holds 73,733 shares or 0.21% of its portfolio. Manufacturers Life Insur The holds 0.1% or 651,167 shares in its portfolio. Hood River Capital Mngmt Ltd Liability reported 129 shares. Great West Life Assurance Com Can stated it has 431,992 shares. 166,175 were accumulated by Gulf Comml Bank (Uk). Chevy Chase Tru Hldgs has 1.16 million shares. Victory Cap Management reported 0.15% of its portfolio in NVIDIA Corporation (NASDAQ:NVDA). Gemmer Asset Mgmt Ltd Liability Company stated it has 346 shares or 0.02% of all its holdings. Metropolitan Life Ins Communications Ny has invested 0.22% in NVIDIA Corporation (NASDAQ:NVDA).

Coatue Management Llc decreased Hain Celestial Group Inc (NASDAQ:HAIN) stake by 93,316 shares to 2.06 million valued at $80.22M in 2016Q4. It also reduced Apple Inc (NASDAQ:AAPL) stake by 3.31 million shares and now owns 3.19M shares. Netflix Inc (NASDAQ:NFLX) was reduced too.

Since March 1, 2017, it had 0 insider buys, and 11 insider sales for $67.44 million activity. SEAWELL A BROOKE sold 3,107 shares worth $434,980. Byron Michael sold $3.50 million worth of stock or 25,507 shares. Another trade for 50,000 shares valued at $8.23 million was made by COXE TENCH on Friday, June 9. On Friday, March 17 Kress Colette sold $5.63 million worth of NVIDIA Corporation (NASDAQ:NVDA) or 53,458 shares. $9.23M worth of NVIDIA Corporation (NASDAQ:NVDA) shares were sold by Shoquist Debora. Shares for $325,048 were sold by Drell Persis on Thursday, May 18. Another trade for 133,542 shares valued at $14.49 million was made by Puri Ajay K on Thursday, March 30.

Among 43 analysts covering Nvidia Corporation (NASDAQ:NVDA), 23 have Buy rating, 5 Sell and 15 Hold. Therefore 53% are positive. Nvidia Corporation had 143 analyst reports since August 3, 2015 according to SRatingsIntel. UBS maintained NVIDIA Corporation (NASDAQ:NVDA) on Monday, August 14 with “Buy” rating. Stifel Nicolaus downgraded NVIDIA Corporation (NASDAQ:NVDA) on Wednesday, April 6 to “Neutral” rating. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, June 28 report. Wedbush maintained NVIDIA Corporation (NASDAQ:NVDA) on Friday, May 13 with “Outperform” rating. The company was upgraded on Monday, November 16 by Canaccord Genuity. The firm has “Outperform” rating given on Friday, August 12 by RBC Capital Markets. BMO Capital Markets maintained NVIDIA Corporation (NASDAQ:NVDA) on Tuesday, August 8 with “Sell” rating. The firm earned “Buy” rating on Friday, March 18 by Argus Research. The firm has “Buy” rating by B. Riley & Co given on Tuesday, October 25. TH Capital downgraded NVIDIA Corporation (NASDAQ:NVDA) on Monday, February 6 to “Neutral” rating.